Articles
Helio Genomics Reveals Impressive Findings on New Approach to Colon Cancer Detection
Helio Genomics, the creator of the HelioLiver test, recently evaluated its Multimodal Epigenetic Sequencing Assay (MESA) for colon cancer detection. Their findings suggest that combining cell-free DNA (cfDNA) methylation features
February 20, 2023